Literature DB >> 31890685

The effects of alpha-lipoic acid supplementation on fasting glucose and lipid profiles among patients with stroke: a systematic review and meta-analysis of randomized controlled trials.

Reza Tabrizi1, Afshin Borhani-Haghighi2, Naghmeh Mirhosseini3, Kamran B Lankarani4, Ahmad Naghibzadeh-Tahami5, Maryam Akbari1, Seyed Taghi Heydari4, Mojgan Sangari6, Fariba Kolahdooz7, Fariba Raygan8, Zatollah Asemi9.   

Abstract

BACKGROUND AND
OBJECTIVE: Stroke is a devastating condition with long-term comorbidities including metabolic abnormalities. Alpha lipoic acid (ALA), with its antioxidant properties, might improve metabolic status of patients, though current evidence is still inclusive. This systematic review of randomized controlled trials (RCTs) was conducted to summarize the existing evidence regarding the effects of ALA supplementation on fasting glucose and lipid profiles among patients with stroke.
METHODS: We searched Cochrane Library, EMBASE, MEDLINE, and Web of Science from 1990 until April 5th, 2018. The relevant randomized-controlled articles, based on defined key words, were included in the analyses. Two independent researchers investigated study eligibility, extracted data, and assessed the risk of bias for included studies. Heterogeneity among included studies was tested using Q-test and I2 statistics. Random-effects models were applied to pool the data and standardized mean differences (WMD) were considered as summary effect size.
RESULTS: A total of five studies (140 patients in each intervention group) were included in our meta-analysis. The findings showed that ALA supplementation significantly decreased fasting glucose levels (WMD -36.93 mg/dL; 95% CI, -65.58, -8.28; P = 0.01; I2 = 85.0%) in patients with stroke. We found no significant effect of ALA supplementation on triglycerides (WMD -7.45 mg/dL; 95% CI, -51.35, 36.45; P = 0.739; I2 = 83.9%), total cholesterol (WMD -23.23 mg/dL; 95% CI, -48.07, 1.62; P = 0.067; I2 = 80.5%), LDL-cholesterol (WMD -10.46 mg/dL; 95% CI, -21.01, 0.09; P = 0.052; I2 = 47.4%) and HDL-cholesterol levels (WMD -3.02 mg/dL; 95% CI, -20.18, 14.14; P = 0.730; I2 = 85.8%).
CONCLUSIONS: This meta-analysis suggested the beneficial impacts of ALA supplementation in improving fasting glucose of patients diagnosed with stroke. © Springer Nature Switzerland AG 2019.

Entities:  

Keywords:  Alpha-lipoic acid; Lipid profiles; Meta-analysis; Stroke

Year:  2019        PMID: 31890685      PMCID: PMC6915248          DOI: 10.1007/s40200-019-00423-0

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  35 in total

1.  Probability of stroke: a risk profile from the Framingham Study.

Authors:  P A Wolf; R B D'Agostino; A J Belanger; W B Kannel
Journal:  Stroke       Date:  1991-03       Impact factor: 7.914

2.  Alpha-lipoic acid reduces body weight and regulates triglycerides in obese patients with diabetes mellitus.

Authors:  Azra Okanović; Besim Prnjavorac; Edin Jusufović; Rifat Sejdinović
Journal:  Med Glas (Zenica)       Date:  2015-08

3.  The effects of lipoic acid and α-tocopherol supplementation on the lipid profile and insulin sensitivity of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial.

Authors:  Andreia Madruga de Oliveira; Patrícia Helen Carvalho Rondó; Liania Alves Luzia; Francisco Homero D'Abronzo; Vanessa Kristine Illison
Journal:  Diabetes Res Clin Pract       Date:  2011-03-02       Impact factor: 5.602

4.  Effects of vitamin D supplementation on insulin sensitivity and androgen levels in vitamin-D-deficient polycystic ovary syndrome patients.

Authors:  Cihan Karadağ; Tevfik Yoldemir; Dilek Gogas Yavuz
Journal:  J Obstet Gynaecol Res       Date:  2017-11-02       Impact factor: 1.730

5.  α-Lipoic acid treatment of aged type 2 diabetes mellitus complicated with acute cerebral infarction.

Authors:  L Zhao; F-X Hu
Journal:  Eur Rev Med Pharmacol Sci       Date:  2014       Impact factor: 3.507

6.  The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Golara Mirmasoumi; Mohammad Fazilati; Fatemeh Foroozanfard; Zahra Vahedpoor; Samaneh Mahmoodi; Mohsen Taghizadeh; Nazanin Kazemi Esfeh; Maryam Mohseni; Hassan Karbassizadeh; Zatollah Asemi
Journal:  Exp Clin Endocrinol Diabetes       Date:  2017-11-08       Impact factor: 2.949

7.  Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Edward C Jauch; Jeffrey L Saver; Harold P Adams; Askiel Bruno; J J Buddy Connors; Bart M Demaerschalk; Pooja Khatri; Paul W McMullan; Adnan I Qureshi; Kenneth Rosenfield; Phillip A Scott; Debbie R Summers; David Z Wang; Max Wintermark; Howard Yonas
Journal:  Stroke       Date:  2013-01-31       Impact factor: 7.914

8.  Research on the nutrition and cognition of high-risk stroke groups in community and the relevant factors.

Authors:  N-N Zhao; K-X Zeng; Y-L Wang; P-J Sheng; C-Z Tang; P Xiao; X-W Liu
Journal:  Eur Rev Med Pharmacol Sci       Date:  2017-12       Impact factor: 3.507

9.  Vitamin D Decreases Serum VEGF Correlating with Clinical Improvement in Vitamin D-Deficient Women with PCOS: A Randomized Placebo-Controlled Trial.

Authors:  Mohamad Irani; David B Seifer; Richard V Grazi; Sara Irani; Zev Rosenwaks; Reshef Tal
Journal:  Nutrients       Date:  2017-03-28       Impact factor: 5.717

10.  Alpha-lipoic acid reduces LDL-particle number and PCSK9 concentrations in high-fat fed obese Zucker rats.

Authors:  Bradley Carrier; Shin Wen; Sophia Zigouras; Richard W Browne; Zhuyun Li; Mulchand S Patel; David L Williamson; Todd C Rideout
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

View more
  1 in total

1.  Efficacy and safety of oral alpha-lipoic acid supplementation for type 2 diabetes management: a systematic review and dose-response meta-analysis of randomized trials.

Authors:  Aliyu Tijani Jibril; Ahmad Jayedi; Sakineh Shab-Bidar
Journal:  Endocr Connect       Date:  2022-09-26       Impact factor: 3.221

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.